Shionogi Of Japan Wins U.S. Patent Fight To Protect Its Crestor Drug
This article was originally published in PharmAsia News
Executive SummaryJapan's Shionogi won a victory in a U.S. court that upheld the firm's patent for Crestor (rosuvastatin), a leading anti-cholesterol drug
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.